Disruptions in substrate availability, co-factor balance, or recycling processes—due to oxidative stress, metabolic disorders, or nutrient deficiencies—can impair eNOS activity and reduce NO bioavailability (Figure 5). The gene discussed is NOS3; the disease is metabolic disease.